Chair: Shunya Nakane, MD, PhD (Department of Neurology, Faculty of Medicine, Academic Research Division, University of Toyama – Toyama, Japan)
Optimization for Symptom Stabilization and Oral Corticosteroid Reduction with Efgartigimod: Insights from Clinical Practice in gMG
Satoru Oji, MD, PhD (Department of Neurology, Saitama Medical University General Medical Center – Saiatama, Japan)
Key points of Efgartigimod Treatment Strategy based on the Japanese MG Guidelines 2025 Supplement
Hiroyuki Murai, MD, PhD (Department of Neurology, International University of Health and Welfare – Tochigi, Japan)